30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: SpineGuard

€4.4MM (~US $5.1MM), -4% (U.S. ~$3.7MM, -2.8%; ex-U.S. ~$1.3MM, -6.8%)

  • Geographic growth: France +21%, Germany +73%, Switzerland +43%
  • Promising results offset by absence of revenue in Brazil (vs. €128,000 in 2013) and -68% decrease in Belgium, The Netherlands and Italy as collateral consequence of the ongoing acquisition of its distributor (Biomet) by Zimmer
  • >35,000 PediGuard procedures performed since introduction